SCHEMBL13379879

SCHEMBL13379879

CN1C(OO)CCC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329317 0.69 — —
SCHEMBL17987080 0.65 — —
SCHEMBL15934156 0.65 — —
SCHEMBL1698769 0.64 CHRM2 (0.32) —
SCHEMBL1698770 0.64 CHRM2 (0.32) —
SCHEMBL23194386 0.62 TSHR (0.31) —
SCHEMBL25543300 0.61 CHRM2 (0.33) —
SCHEMBL21709965 0.61 CHRM2 (0.36) —
SCHEMBL23205840 0.61 CHRM2 (0.33) —
SCHEMBL15932140 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357820-A1 TEST METHOD FOR MILD COGNITIVE IMPAIRMENT, TEST REAGENT FOR MILD COGNITIVE IMPAIRMENT, AND METHOD FOR SCREENING THERAPEUTIC CANDIDATE SUBSTANCES FOR MILD COGNITIVE IMPAIRMENT BIORADICAL RESEARCH INSTITUTE CORP. (JP) 2023-11-09 — — US disclosed
US-7700778-B2 Acylated piperidine derivatives as melanocortin-4 receptor agonists MERCK SHARP & DOHME CORP. (US) 2010-04-20 — — US disclosed
Send feedback